NuCana (NCNA) Long-Term Deferred Tax (2017 - 2025)
NuCana (NCNA) reported Long-Term Deferred Tax of $155629.4 for Q4 2025, up 7.3% on a YoY basis from $145035.7 in Q4 2024, and down 6.23% sequentially from $165971.5 in Q3 2025.
NuCana (NCNA) Long-Term Deferred Tax (2017 - 2025) Analysis & Trends
NuCana (NCNA) has 9 years of Long-Term Deferred Tax data on file, last reported at $155629.4 in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax rose 7.3% year-over-year to $155629.4; the trailing twelve-month figure through Dec 2025 stood at $155629.4 (up 7.3% YoY), and the FY2025 full-year result was $154265.7, up 6.8% from the prior year.
- Long-Term Deferred Tax eased to $155629.4 in Q4 2025, from $165971.5 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $219581.7 in Q3 2024 to a low of $46871.8 in Q3 2021.
- A 5-year average of $133044.1 and a median of $143219.9 in 2023 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax surged 138.87% in 2022 and retreated 29.54% in 2025, its largest moves.
- Tracing NCNA's Long-Term Deferred Tax over 5 years: stood at $80880.6 in 2021, then surged by 49.37% to $120811.6 in 2022, then soared by 46.91% to $177484.7 in 2023, then slipped by 18.28% to $145035.7 in 2024, then increased by 7.3% to $155629.4 in 2025.
- Business Quant data shows NCNA's Long-Term Deferred Tax at $155629.4 in Q4 2025, $165971.5 in Q3 2025, and $149413.1 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 155,629.45 |
| Sep 30, 2025 | 165,971.54 |
| Jun 30, 2025 | 149,413.12 |
| Mar 31, 2025 | 146,102.06 |
| Dec 31, 2024 | 145,035.71 |
| Sep 30, 2024 | 219,581.73 |
| Jun 30, 2024 | 212,053.09 |
| Mar 31, 2024 | 197,888.84 |
| Dec 31, 2023 | 177,484.72 |
| Sep 30, 2023 | 160,868.97 |
| Jun 30, 2023 | 141,404.04 |
| Mar 31, 2023 | 130,059.52 |
| Dec 31, 2022 | 120,811.62 |
| Sep 30, 2022 | 111,962.09 |
| Jun 30, 2022 | 100,745.14 |
| Mar 31, 2022 | 91,244.83 |
| Dec 31, 2021 | 80,880.64 |
| Sep 30, 2021 | 46,871.83 |
| Jun 30, 2021 | 51,715.95 |
| Mar 31, 2021 | 55,156.83 |